Poolbeg Pharma PLC (POLB)

ORD 0.02P

Sell: 3.80p|Buy: 4.20p|Change: 0.05 (1.27%)

Open

3.95p

Previous close

3.95p

Trade high

4.20p

Volume

612,217

Year high

7.50p

Year low

2.25p

Dividend yield

–

Market capitalisation

£27.89 mn

P/E ratio

–

ISIN

GB00BKPG7Z60

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Share price

Performance 17/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Poolbeg Pharma PLC	+ 2.60
More...

Company profile

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to development of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
18/12/2025	03:19:23	4.02	476	19.14
18/12/2025	03:06:47	3.881	2,694	104.55
18/12/2025	03:04:39	3.881	11,785	457.38
18/12/2025	02:58:02	4.02	1,187	47.72
18/12/2025	02:39:19	3.881	20,000	776.20

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.